Research News and Research

RSS

Bathroom scale performs electrocardiograms

The Instrumentation, Sensors and Interfaces (ISI) Group has developed an intuitive and cost-effective scale, which, as well as measuring weight, also records the electrical activity of the heart from foot and hand contact. The device demonstrates the usefulness of telemedicine, which is particularly appropriate for people who need frequent heart checkups.

30 Jul 2012

Ebola outbreak identified in Uganda

"The world's first major outbreak of Ebola hemorrhagic fever since 2009 has killed at least 14 of 20 people infected in a remote area of midwestern Uganda," the Wall Street Journal reports (Bariyo/McKay, 7/29).

30 Jul 2012

White House projections include steep reductions in Medicare, Medicaid spending

Buried in the White House's annual "mid-session review" budget update on Friday are some steep reductions in projected spending for some of the government's largest expenditures -- Medicare, Medicaid, Social Security and interest on the debt.

30 Jul 2012

GenomeQuest's genomic decision support system achieves HIPAA compliance

GenomeQuest Inc., a global provider of large-scale genomic software applications, today announced that its GQ-Dx genomic decision support system for the production of clinical-grade diagnostic reports from next-generation sequencing (NGS) runs now meets Health Insurance Portability and Accountability Act (HIPAA) security and privacy standards.

30 Jul 2012

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has earned a development milestone payment from GlaxoSmithKline, totaling $3.2 million. The milestone payment is related to progress in the companies' collaboration on the use of VaxiRNA technology for the production of GSK influenza vaccine.

30 Jul 2012

Court backs Obama administration crackdown on drug company execs

A federal appeals court backed the Obama administration's drive to levy greater punishments on pharmaceutical executives tied to corporate wrongdoing, saying the administration could effectively derail the executives' careers by barring them from doing business with federal programs including Medicare.

30 Jul 2012

Bruker introduces high-resolution microscope for research in biological dynamics

At the Microscopy & Microanalysis (M&M) 2012 Annual Meeting, Bruker today announced the Dimension FastScan Bio™ Atomic Force Microscope (AFM), which enables high-resolution microscopy research in biological dynamics.

From Bruker Nano Surfaces and Metrology 30 Jul 2012

Some AIDS experts view health law coverage expansion with hope

Meanwhile, the Obama administration announced it would add new funds to increase access to HIV/AIDS care, but questions remain about whether it will be enough to address waiting lists for the drug assistance program. Also in the news, reports on treatment developments.

30 Jul 2012

Encouraging results from Tonix TNX-102 SL clinical trial for fibromyalgia syndrome

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, announces that the clinical portion of a human study of a solution version of TNX-102 2.4 mg sublingual tablets has completed.

30 Jul 2012

Concierge medicine buys patients more of doctors' time and attention

The Los Angeles Times reports that a growing number of California physicians are turning toward this type of practice.

30 Jul 2012

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line data from its open-label phase IIIb trial evaluating XIAFLEX for the treatment of adult Dupuytren's contracture patients with multiple palpable cords. The Company enrolled 60 patients at eight sites throughout the U.S. and Australia.

30 Jul 2012

Scientists identify new gene responsible for genetic form of blindness in newborns

One of the mysteries of blindness has been solved. A team of international scientists in collaboration with the Research Institute of the McGill University Health Centre (RI MUHC) identified a new gene responsible for Leber Congenital Amaurosis (LCA), a devastating genetic form of blindness in newborns.

30 Jul 2012

Political cartoon: 'Testing My Patience'

Kaiser Health News provides a fresh take on health policy developments with "Testing My Patience" by Roy Delgado.

30 Jul 2012

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

The antioxidants that we mainly looked at were selenium, vitamin C and vitamin E. They are chemicals which inactivate pro-oxidants or free radicals. Smoking and normal metabolism can lead to the production of free radicals.

30 Jul 2012

Nurse burnout leads to higher healthcare-associated infection rates

Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

30 Jul 2012

Promising implications for improving cellular immunotherapy for treatment of cancer

New research from the Trudeau Institute laboratory of Dr. Edward L. Pearce (Washington University) has promising implications for improving a treatment for cancer known as cellular immunotherapy. The findings were just published in the The Journal of Immunology.

30 Jul 2012

Osiris second quarter biosurgery product revenue increases 43% from previous quarter

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter ended June 30, 2012.

30 Jul 2012

FDA clears Proteus ingestible sensor

Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration has cleared its ingestible sensor for marketing as a medical device. The ingestible sensor (formally referred to as the Ingestion Event Marker or IEM) is part of the Proteus digital health feedback system, an integrated, end-to-end personal health management system that is designed to help improve patients' health habits and connections to caregivers.

30 Jul 2012

Assay Depot launches virtual research laboratory

Assay Depot Inc. today announced the launch of a virtual research laboratory. Developed in partnership with AstraZeneca, the virtual laboratory is a powerful vendor relationship management (VRM) system that gives researchers easy access to a distributed network of thousands of research service providers located inside and outside the company.

30 Jul 2012

First Edition: June 30, 2012

Today's headlines include recent reports about both the policies and politics related to the health law's implementation.

30 Jul 2012

Research News and Research

Bathroom scale performs electrocardiograms

Ebola outbreak identified in Uganda

White House projections include steep reductions in Medicare, Medicaid spending

GenomeQuest's genomic decision support system achieves HIPAA compliance

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Court backs Obama administration crackdown on drug company execs

Bruker introduces high-resolution microscope for research in biological dynamics

Some AIDS experts view health law coverage expansion with hope

Encouraging results from Tonix TNX-102 SL clinical trial for fibromyalgia syndrome

Concierge medicine buys patients more of doctors' time and attention

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Scientists identify new gene responsible for genetic form of blindness in newborns

Political cartoon: 'Testing My Patience'

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

Nurse burnout leads to higher healthcare-associated infection rates

Promising implications for improving cellular immunotherapy for treatment of cancer

Osiris second quarter biosurgery product revenue increases 43% from previous quarter

FDA clears Proteus ingestible sensor

Assay Depot launches virtual research laboratory

First Edition: June 30, 2012

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery